STAT3 and neoplasm: Additionally, in triple-negative breast cancer, a micropeptide named ASRPS has been identified and shown to regulate the STAT3/VEGF signalling pathway, bind directly to STAT3, inhibits STAT3 phosphorylation, and reduce VEGF expression, thereby inhibiting tumour angiogenesis [58].